FUJIFILM Biosciences announced the company has officially changed its legal name from FUJIFILM Irvine Scientific, Inc. to FUJIFILM Biosciences Inc., effective 1 January, 2026. The FUJIFILM Biosciences’s name builds upon the company’s roots as a pioneer in the cell culture media industry that through a core focus on people, innovation and quality now serves a much broader life science community and customers.

FUJIFILM Biosciences continues to be dedicated to its customers with a focus on empowering scientists and researchers at every stage of discovery, development and commercialisation. By offering a comprehensive portfolio of products and services in cell culture media, feeds, specialty chemicals and reagents, single-use technologies and human-induced pluripotent stem cell capabilities, the company supports and helps accelerate the development of life-changing treatments that can improve patient outcomes worldwide.

“All of us at FUJIFILM Biosciences take immense pride in being a people-focused company that empowers our colleagues to create an exceptional customer experience. We utilise our 55-year legacy of deep industry knowledge to collaboratively develop innovative solutions and technologies that are supplied from our global network of manufacturing facilities. With this approach and our ongoing investments, we look ahead to a strong future with our employees, customers and partners around the world,” said Brandon Pence, President and Chief Operating Officer, FUJIFILM Biosciences.